These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20804464)

  • 1. Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy.
    Saarne T; Neimert-Andersson T; Grönlund H; Jutel M; Gafvelin G; van Hage M
    Allergy; 2011 Feb; 66(2):255-63. PubMed ID: 20804464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.
    Neimert-Andersson T; Thunberg S; Swedin L; Wiedermann U; Jacobsson-Ekman G; Dahlén SE; Scheynius A; Grönlund H; van Hage M; Gafvelin G
    Allergy; 2008 May; 63(5):518-26. PubMed ID: 18394125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher immunoglobulin E antibody levels to recombinant Fel d 1 in cat-allergic children with asthma compared with rhinoconjunctivitis.
    Grönlund H; Adédoyin J; Reininger R; Varga EM; Zach M; Fredriksson M; Kronqvist M; Szepfalusi Z; Spitzauer S; Grönneberg R; Valenta R; Hedlin G; van Hage M
    Clin Exp Allergy; 2008 Aug; 38(8):1275-81. PubMed ID: 18477016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.
    Thunberg S; Neimert-Andersson T; Cheng Q; Wermeling F; Bergström U; Swedin L; Dahlén SE; Arnér E; Scheynius A; Karlsson MC; Gafvelin G; van Hage M; Grönlund H
    Allergy; 2009 Jun; 64(6):919-26. PubMed ID: 19183417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cat sensitization identified by recombinant Fel d 1 several years before symptoms--results from the BAMSE cohort.
    Saarne T; Grönlund H; Kull I; Almqvist C; Wickman M; van Hage M
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):277-83. PubMed ID: 20003163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired allergy diagnostics among parasite-infected patients caused by IgE antibodies to the carbohydrate epitope galactose-α 1,3-galactose.
    Arkestål K; Sibanda E; Thors C; Troye-Blomberg M; Mduluza T; Valenta R; Grönlund H; van Hage M
    J Allergy Clin Immunol; 2011 Apr; 127(4):1024-8. PubMed ID: 21376382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of immunoreactive recombinant cat allergen (Fel d 1): Targeting to antigen-presenting cells.
    Vailes LD; Sun AW; Ichikawa K; Wu Z; Sulahian TH; Chapman MD; Guyre PM
    J Allergy Clin Immunol; 2002 Nov; 110(5):757-62. PubMed ID: 12417885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Allergen-Specific IgE Recognition Profiles and Cumulative Specific IgE Levels Associated with Phenotypes of Cat Allergy.
    Riabova K; Karsonova AV; van Hage M; Käck U; Konradsen JR; Grönlund H; Fomina D; Beltyukov E; Glazkova PA; Semenov DY; Valenta R; Karaulov A; Curin M
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy.
    Martínez-Gómez JM; Johansen P; Rose H; Steiner M; Senti G; Rhyner C; Crameri R; Kündig TM
    Allergy; 2009 Jan; 64(1):172-8. PubMed ID: 19076537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of endotoxin on the production of IgE, IgG1 and IgG2a antibodies against the cat allergen Fel d 1 in mice.
    Ormstad H; Groeng EC; Duffort O; Løvik M
    Toxicology; 2003 Jun; 188(2-3):309-18. PubMed ID: 12767700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cat lipocalin Fel d 7 and its cross-reactivity with the dog lipocalin Can f 1.
    Apostolovic D; Sánchez-Vidaurre S; Waden K; Curin M; Grundström J; Gafvelin G; Cirkovic Velickovic T; Grönlund H; Thomas WR; Valenta R; Hamsten C; van Hage M
    Allergy; 2016 Oct; 71(10):1490-5. PubMed ID: 27289080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.
    Hales BJ; Chai LY; Hazell L; Elliot CE; Stone S; O'Neil SE; Smith WA; Thomas WR
    J Allergy Clin Immunol Pract; 2013; 1(6):656-65.e1-5. PubMed ID: 24565714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
    Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
    BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.